DOCSLIB.ORG

Virus Purification, Rna Extraction, and Targeted

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Virus Purification, Rna Extraction, and Targeted VIRUS PURIFICATION, RNA EXTRACTION, AND TARGETED GENOME CAPTURE IN ONE CHIP Miyako Niimi1*, Taisuke Masuda1, Kunihiro Kaihatsu2, Nobuo Kato2, and Fumihito Arai1 1Nagoya University, JAPAN and 2Osaka University, JAPAN ABSTRACT In this research, we demonstrated a microfluidic chip to pretreat the samples for viral genome assay. The microfluidic chip has the following three functions; (1) Virus purification and enrichment, (2) Viral RNA extraction, and (3) Capture of the targeted virus genome. (1) Hydroxyapatite chromatography, Boom method, and PNA (2) (Peptide Nucleic Acid) were used for the above three (3) functions, respectively. These three functions were integrated in one chip. Furthermore PNA immobilized on the glass can detect the targeted virus genome so that in situ virus detection would be possible by anybody, anywhere, anytime. KEYWORDS: Virus purification, RNA extraction and detection, Infectious disease diagnosis INTRODUCTION For the purpose of diagnosing the infectious diseases Figure 1. Concept of the microfluidic chip. The microflu- quickly and accurately, DNA sequencers for gene analysis idic chip consists of the three parts: (1) hydroxyapatite- of infectious viruses have been developed rapidly. The packed microcolumn for virus purification, (2) silica- latest DNA sequencers can treat the massive numbers of packed microcolumn for viral RNA extraction, and (3) samples such as saliva and nasal at one time. However, it PNA immobilized glass for capture of the targeted virus is necessary to purify and enrich the virus and extract the genome. viral RNA in the sample as the pretreatments before gene (1) (2) analysis. Hydroxyapatite chromatography[1] have been Sample Elution Buffer used extensively for purification and fractionation of Hydroxy- various biochemical substances such as protein and virus. apatite Viral RNA is specifically adsorbed to silica when the Protein solution contains chaotropic agent such as guanidine salt. Virus The adsorbed RNA can be eluted by low-salt buffer such as nuclease-free water. This method is called Boom method[2] and has been used very extensively in many (3) (4) kinds of commercial kit for RNA extraction. However, Lysis Buffer both of hydroxyapatite chromatography and conventional commercial kit for RNA extraction require the large and Silica expensive equipments. They also need cumbersome RNA processes by human hand. Thus it takes very long time to complete the pretreatment processes for viral gene analysis although the throughput of DNA sequencers have been getting higher and higher. Elution Buffer In this research, we demonstrated a microfluidic chip Figure 2. The each process carried out in the microfluidic to pretreat the samples. The microfluidic chip utilizes two chip. (1)Introduce the sample into the hydroxyapatite- microcolumns; one is a hydroxyapatite-packed packed microcolumn. (2)Elute the impurities such as pro- microcolumn for virus purification and the other is a teins in the sample. (3)Introduce the lysis buffer into the silica-packed microcolumn for viral RNA extraction. hydroxyapatite-packed microcolumn so that the lysate is Furthermore PNA[3] immobilized on the glass is integrated introduced into the silica-packed microcolumn. on the microfluidic chip to detect the targeted virus genome (4)Introduce the elution buffer into the silica-packed so that in situ virus detection would be possible by anybody, microcolumn to extract the viral RNA. anywhere, anytime. 978-0-9798064-6-9/µTAS 2013/$20©13CBMS-0001 482 17th International Conference on Miniaturized Systems for Chemistry and Life Sciences 27-31 October 2013, Freiburg, Germany THEORY Figure 1 shows the concept of our microfluidic chip. Virus genome The microfluidic chip consists of the three parts; (1)hydroxyapatite-packed column for virus purification, (2)silica-packed column for viral RNA extraction, and (3)PNA-immobilized glass for capture of virus genome. PNA Figure 2 shows the each process carried out in the microfluidic chip. The sample is introduced into the hydroxyapatite-packed column for virus purification. The impurities such as proteins are removed and the viruses are purified by hydroxyapatite chromatography. The Virus Protein purified viruses are subsequently introduced into the Luminol Substrate silica-packed column for viral RNA extraction by Boom HRP nucleic acid extraction method. The extracted viral RNAs 3-aminophthalic acid dianion (Ex; 430 nm, Em; 460 nm) are subsequently introduced into the detection port and the targeted virus genomes are captured by PNA as Figure 3. Concept of capture and detection of the tar- shown in figure 3. PNA is an RNA/DNA mimic in which geted virus genome by PNA. Virus genome is captured the phosphate deoxyribose backbone is replaced by a by PNA immobilized on the glass. The HRP is ad- neutral amide backbone composed of N-(2-aminoethyl) sorbed to the viral protein by antigen-antibody reac- glycine linkage as shown in figure 4. Base pairing by tion. The Luminol substrate is captured by the HRP PNAs is not affected by intrastrand electrostatic and 3-aminophthalic acid dianion is generated. repulsion and occurs with high affinity and enhanced rates of association with strict sequence specificity. As shown in figure 3, horseradish peroxidase(HRP) is adsorbed to the viral protein by antigen-antibody reaction. Luminol substrate is captured by the enzyme and 3- aminophthalic acid dianion is generated. The supernatant is collected and the fluorescence intensity of 3- aminophthalic acid dianion is measured by the fluorescence spectrometer. EXPERIMENTAL The proposed microfluidic chip consists of a PDMS (polydimethylsiloxane) microchannel and a PDMS substrate. Figure 5 shows the fabrication process of the PDMS microchannel and assembly method of the microchannel and the substrate. The PDMS microchannel Figure 4: Structure of PNA. PNA is an RNA/DNA mimic in was produced by replica molding using a master mold which the phosphate deoxyribose backbone is replaced by a fabricated by photolithography. The negative-type neutral amide backbone composed of N-(2-aminoethyl) gly- photoresist (SU-8 3050, Kayaku Microchem, Co., Ltd.) was spin coated on the silicon substrate. After prebaking, cine linkage ultraviolet light was exposed through a photomask to 1. SU-8 Coating 3. Development 6. Assembly produce a microchannel pattern using a mask aligner. After exposure, the substrate was developed and rinsed. SU-8 Then the PDMS was molded by patterned substrate. 4. Molding Plasma Finally, the PDMS microchannel and the substrate were Si-Wafer bonded by air plasma. The height of channel was 100 m. PDMS Figure 6 shows the both of the two microcolumns. In the 2. Exposure upstream and downstream parts of the microcolumns, the Heating cylindrical micropillars 50 m in diameter were included UV 5. Removing to hold the hydroxyapatite particles and silica particles in the column. The distance between the micropillars was 20 m so that the hydroxyapatite particles 40 m in Figure 5: Fabrication process of the proposed microfluidic diameter and the silica particles 30 m in diameter can be chip. The PDMS microchannel was produced by replica hold in the microculumn. molding using a master mold fabricated by photolithogra- Targeted genome capture by PNA was demonstrated phy. using a glass substrate on which PNA was immobilized. The PNA base sequence was designed to capture influenza A/H1N1 virus genome selectively. Three samples 0, 7.0x103, 7.0x104 pfu/mL in virus titer were 483 applied to the PNA immobilized glass substrate to demonstrate the effect of the virus titer on detection sensitivity. Furthermore the virus genomes of influenza Hydroxyapatite Silica A/H1N1, A/H3N2, and B were applied to the PNA immobilized glass substrate to demonstrate the specificity of the designed PNA. Micropillar Micropillar RESULTS AND DISCUSSION Figure 7 and figure 8 show the results of capture of 100 m influenza virus genome by PNA. The fluorescence inten- Figure 6: Left: Hydroxyapatite-packed microcolumn. sity was measured by the fluorescence spectrometer. In Right: Silica-packed microcolumn. figure 7, it was found that the fluorescence intensity be- came stronger as the virus titer increased. And in figure 8, Both of the columns were fabricated using it was found that PNA selectively captured influenza photolithography. A/H1N1 virus genome. while it didn’t capture influenza A/H3N2 and influenza B virus. From these results, it was 400 Virus titer [pfu/mL] suggested that PNA can diagnose the virus titer and subtype. 0 7.0x103 CONCLUSION 4 In this research we proposed a microfluidic chip for 7.0x10 the pretreatment of samples before gene analysis. All of the pretreatment processes for virus gene analysis can be [a.u.] carried out in one microfluidic chip. With our microfluid- ic chip, it would be possible to detect the virus genome in bodily fluid in situ. If several kinds of PNA that capture Fluorescence intensity the representative virus genome such as influenza A, in- 0 fluenza B, and norovirus is immobilized on the glass sub- 400 450 500 strate, parallel diagnosis for different diseases would be Wavelength [nm] possible. Therefore the rapid diagnosis of infectious dis- ease would be possible. Furthermore, even though the all Figure 7. Results of capture of influenza virus genome PNA immobilized on the microfluidic chip don’t capture by PNA. The fluorescence intensity became stronger as the virus genome in a sample and infectious cause cannot the virus titer increased. be identified, it would be possible to analyze the extract- ed viral RNA using DNA sequencers. We are sure that 400 rapid, easy, and accurate diagnosis of infectious diseases would be possible using a combination of our microfluid- 0 ic chip and DNA sequencers. H1N1 ACKNOWLEDGEMENTS H3N2 This work was supported in part by the Management [a.u.] Expenses Grants for National Universities Corporations B from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). Fluorescence intensity 0 REFERENCES 400 450 500 [1] “Virus Detection by On-chip Hydroxyapatite Chro- Wavelength [nm] matography”, M. Niimi et al., Proc. of MicroTAS, 605 (2011) Figure 8.
Load more

Recommended publications
  • Evaluation of Six Methods for Extraction and Purification of Viral DNA from Urine and Serum Samples
    NEW MICROBIOLOGICA, 29, 111-119, 2006 Evaluation of six methods for extraction and purification of viral DNA from urine and serum samples Massimiliano Bergallo, Cristina Costa, Giorgio Gribaudo, Sonia Tarallo, Sara Baro, Alessandro Negro Ponzi, Rossana Cavallo Department of Public Health and Microbiology, Virology Unit, University of Turin, Italy SUMMARY The sensitivity and reliability of PCR for diagnostic and research purposes require efficient unbiased procedures of extraction and purification of nucleic acids. One of the major limitations of PCR-based tests is the inhibition of the amplification process by substances present in clinical samples. This study used specimens spiked with a known amount of plasmid pBKV (ATCC 33-1) to compare six methods for extraction and purification of viral DNA from urine and serum samples based on recovery efficiency in terms of yield of DNA and percentage of plasmid pBKV recovered, purity of extracted DNA, and percentage of inhibition. The most effective extraction methods were the phenol/chloroform technique and the silica gel extraction procedure for urine and serum samples, respectively. Considering DNA purity, the silica gel extraction procedure and the phenol/chloroform method produced the most satisfactory results in urine and serum samples, respectively. The presence of inhibitors was overcome by all DNA extraction techniques in urine samples, as evidenced by semiquantitative PCR amplification. In serum samples, the lysis method and the proteinase K procedure did not completely overcome the presence of inhibitors. KEY WORDS: PCR, DNA extraction, BKV, PCR inhibitors Received February 8, 2006 Accepted March 14, 2006 INTRODUCTION sequences has allowed the determination of pres- ence and quantification of specific viral genes and Molecular biology techniques represent a pow- sequences in biological matrices.
    [Show full text]
  • Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics Kevin Maisheng Koo Bachelor of Science (Hons I)
    Advancing Gene Fusion Detection towards Personalized Cancer Nanodiagnostics Kevin Maisheng Koo Bachelor of Science (Hons I) A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2017 Australian Institute for Bioengineering and Nanotechnology Abstract Prostate cancer (PCa) is one of the most prevalent non-cutaneous cancers in men, and is also one of the most lethal oncogenic diseases that accounts for a vast majority of male cancer-related deaths. Currently, widespread PCa screening is reliant on the prevailing usage of the FDA-approved blood- based prostate specific antigen (PSA) biomarker. Yet, landmark clinical trials in recent years have indicated that serum PSA screening holds a substantial risk of over-diagnosing low grade indolent PCa which are unlikely to result in mortality. Consequently, this paucity of accurate disease risk stratification during PCa screening has led to a variety of health burden associated with unnecessary biopsies, and over-treatment in a considerable fraction of patient population. Given that the screening shortcoming of the PSA test is outweighing its benefit, there is a clear need for better strategies to improve PCa risk stratification and accurately detect high-grade aggressive PCa molecular subtypes at an early stage for timely personalized treatment. To address this PCa screening conundrum, the research work described in this thesis primarily embodies a bipartite strategy which pairs together the use of next-generation PCa-specific molecular biomarkers, and the development of innovative nanodiagnostic technologies to target these superior biomarkers. In recent years, massive advances in next-generation sequencing techniques have led to the discoveries of novel PCa molecular targets which possess excellent PCa- specificity (i.e.
    [Show full text]
  • RNA Isolation and Purification for Every Sample, RNA Type, and Application Isolate and Purify RNA with Confidence
    RNA isolation and purification For every sample, RNA type, and application Isolate and purify RNA with confidence RNA isolation is a crucial step in your quest to understand gene expression levels. With all the solutions that Thermo Fisher Scientific has to offer, you can be confident that you’re getting started on the right foot. Go ahead and push the limits of your research. We’ll be there to support you with robust RNA purification kits, trusted RNA tools, and experienced technical support, all backed by nearly 30 years of leadership and innovation in RNA technologies. • Isolate from any sample type, for any application • Obtain high-purity, intact RNA • Achieve high yields, even from small sample quantities Contents Methods of RNA isolation 4 RNA and sample types 5 RNA applications 6 Organic RNA extraction 8 Spin column RNA extraction 10 Lysate-based RNA extraction 11 Automated RNA purification 12 Transcriptome purification 14 mRNA purification 15 MicroRNA and small RNA purification 16 Viral RNA purification 18 RNA from FFPE samples 20 RNA isolation technology guide 22 Avoiding RNA degradation 26 Tips for handling RNA 27 RNA quantitation 28 Gene expression solutions 30 Gene expression research considerations 31 Superior cDNA synthesis for any application 32 Complete kit with flexible priming options 33 Which instrument fits your needs? 34 Which thermal cycler or PCR instrument fits your needs? 35 RNA technical resources 36 Services and support 37 Ordering information 38 Methods of RNA isolation For every application, sample, and RNA type For over three decades, our scientists have developed and professional support. Our RNA isolation products innovative and robust RNA isolation products designed include organic reagents, columns, sample lysate, and to make your job as a scientist easier.
    [Show full text]
  • Amplication of 0.7Kb Fragment Katg Gene from Clinical Multi Drug Resistant Tuberculosis Isolate in Bali
    Indonesian Journal of Biomedical Sciences Volume 7, Number 2, July-December 2013: 69-72 Print-ISSN: 2085-4773, E-ISSN: 2302-2906. AMPLICATION OF 0.7KB FRAGMENT KATG GENE FROM CLINICAL MULTI DRUG RESISTANT TUBERCULOSIS ISOLATE IN BALI 1Dwiputri, A. W., 2Ratnayani, K., 1Yowani, S. C. 1Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Udayana University, Bali-Indonesia 2Department of Chemistry, Faculty of Mathematics and Natural Sciences, Udayana University, Bali-Indonesia ABSTRACT During last decade has seen a particular increase in the occurrence of drug-resistant of tuberculosis (DR-TB) and multi-DR strains, such as Isoniazid (INH) resistant strains of M. tuberculosis. INH resistance is more frequently associated with mutations in the katG gene. Detection of katG gene mutations can be performed by PCR technique, followed by sequences. The aim of this study is to amplify katG gene region (0,7 Kb) from clinical isolate of MDR-TB in Bali. DNA isolation for PCR was done by Boom method and katG gene amplification was performed under the following conditions: predenaturation at 950C for 15 min; fourty cycles of denaturation at 940C for 1 min, annealing at 560C for 1 min, extension at 720C for 2 min; final extension at 720C for 10 min. The amplicons were detected by 1.5% agarose gel electrophoresis and showed a specific band size at 0.7 kb. This suggests that the fragment of katG gene has been successfully amplified in these areas. Keywords: amplification, katG gene, MDR-TB, 0.7 Kb INTRODUCTION we designed new primers with a longer area of Tuberculosis, caused by M.
    [Show full text]
  • Nederlandse Vereniging Voor Medische Microbiologie
    NEDERLANDS TIJDSCHRIFT VOOR Medische Microbiologie SUPPLEMENT BIJ TWAALFDE JAARGANG, APRIL 2004 Voorjaarsvergadering van de Nederlandse Vereniging voor Medische Microbiologie (NVMM) en de Nederlandse Vereniging voor Microbiologie (NVvM) in samenwerking met: Secties Algemene en Moleculaire Microbiologie, Microbiële Ecologie, Technische Microbiologie en Mycologie; Sectie Algemene Virologie; Sectie Levensmiddelenmicrobiologie; Nederlandse Vereniging voor Medische Mycologie; Werkgemeenschap Microbiële Pathogenese; Werkgroep Epidemiologische Typeringen; Werkgroepen Oost en West Medische Microbiologie; Nederlandse Werkgroep Klinische Virologie; Stichting Kwaliteitsbewaking Medische Microbiologie Papendal, 6 en 7 april 2004 Programma-overzicht Abstracts Auteursindex TWAALFDE J A A R G A N G . APRIL 2004 . SUPPLEMENT 041041_NtvMM_special_2004#20.indd 1 16-03-2004 14:58:04 adv Clindia 041041_NtvMM_special_2004#20.indd 2 16-03-2004 14:58:05 INLEIDING Inleiding Inmiddels is het traditie aan het worden: de Voorjaarsvergadering van de Nederlandse Vereniging voor Microbiologie (NVvM) en de Nederlandse Vereniging voor Medische Microbiologie (NVMM), en wordt op 6 en 7 april 2004 te Papendal gehouden. Ook de formule wordt een traditie: een plenair symposium op dinsdagochtend, dit jaar met als thema ‘Communication’, gevolgd door overwegend thematisch in- gedeelde parallelsessies. De multidisciplinaire, interactieve sessie van vorig jaar was dermate succesvol, dat deze sessievorm dit voorjaar wordt verdubbeld: één over mycobacteriële infecties bij kinderen en de ander over Chlamydia trachomatis en infertiliteit. AIO’s blijven zeer welkom op de Voorjaarsvergadering: zij worden vrijgesteld van inschrijfkosten, mid- dels de ‘Young Investigators Grant’, op voorwaarde dat zij een presentatie houden. Uiteraard is alleen de presenterende auteur van een voordracht of poster vrijgesteld. ‘Communication’ is het onderwerp van het plenaire symposium op dinsdagochtend: communicatie tus- sen micro-organismen onderling en tussen micro-organismen en gastheer.
    [Show full text]
  • A Suitable RNA Preparation Methodology for Whole Transcriptome Shotgun Sequencing Harvested from Plasmodium Vivax‑Infected Patients Catarina Bourgard1, Stefanie C
    www.nature.com/scientificreports OPEN A suitable RNA preparation methodology for whole transcriptome shotgun sequencing harvested from Plasmodium vivax‑infected patients Catarina Bourgard1, Stefanie C. P. Lopes2,3, Marcus V. G. Lacerda2,3, Letusa Albrecht1,4* & Fabio T. M. Costa1* Plasmodium vivax is a world‑threatening human malaria parasite, whose biology remains elusive. The unavailability of in vitro culture, and the difculties in getting a high number of pure parasites makes RNA isolation in quantity and quality a challenge. Here, a methodological outline for RNA‑ seq from P. vivax isolates with low parasitemia is presented, combining parasite maturation and enrichment with efcient RNA extraction, yielding ~ 100 pg.µL−1 of RNA, suitable for SMART‑Seq Ultra‑Low Input RNA library and Illumina sequencing. Unbiased coding transcriptome of ~ 4 M reads was achieved for four patient isolates with ~ 51% of transcripts mapped to the P. vivax P01 reference genome, presenting heterogeneous profles of expression among individual isolates. Amongst the most transcribed genes in all isolates, a parasite‑staged mixed repertoire of conserved parasite metabolic, membrane and exported proteins was observed. Still, a quarter of transcribed genes remain functionally uncharacterized. In parallel, a P. falciparum Brazilian isolate was also analyzed and 57% of its transcripts mapped against IT genome. Comparison of transcriptomes of the two species revealed a common trophozoite‑staged expression profle, with several homologous genes being expressed. Collectively, these results will positively impact vivax research improving knowledge of P. vivax biology. Plasmodium vivax is the most prevalent malaria parasite outside Sub-Saharan Africa, causing the most geographi- cally widespread type of malaria, placing millions of people at risk of infection 1.
    [Show full text]
  • Detection of Mycoplasma Hyopneumoniae by Polymerase Chain Reaction in Swine Presenting Respiratory Problems
    Brazilian Journal of Microbiology (2008) 39:471-476 ISSN 1517-8382 DETECTION OF MYCOPLASMA HYOPNEUMONIAE BY POLYMERASE CHAIN REACTION IN SWINE PRESENTING RESPIRATORY PROBLEMS Yamaguti, M.1*; Muller, E.E.1; Piffer, A.I.2; Kich, J.D.2; Klein, C.S.2; Kuchiishi, S.S.3 1Universidade Estadual de Londrina, Campus Universitário, Londrina, PR, Brasil; 2Embrapa Suínos e Aves, Concórdia, SC, Brasil; 3Universidade Estadual de São Paulo, Jaboticabal, SP, Brasil. Submitted: April 09, 2007; Returned to authors for corrections: January 23, 2008; Approved: July 04, 2008. ABSTRACT Since Mycoplasma hyopneumoniae isolation in appropriate media is a difficult task and impractical for daily routine diagnostics, Nested-PCR (N-PCR) techniques are currently used to improve the direct diagnostic sensitivity of Swine Enzootic Pneumonia. In a first experiment, this paper describes a N-PCR technique optimization based on three variables: different sampling sites, sample transport media, and DNA extraction methods, using eight pigs. Based on the optimization results, a second experiment was conducted for testing validity using 40 animals. In conclusion, the obtained results of the N-PCR optimization and validation allow us to recommend this test as a routine monitoring diagnostic method for Mycoplasma hyopneumoniae infection in swine herds. Key-words: Swine Enzootic Pneumonia, Mycoplasma hyopneumoniae, diagnosis, Nested- PCR. INTRODUÇÃO Nowadays, fastidious microorganisms have been detected by molecular biology techniques, such as DNA or RNA Mycoplasma hyopneumoniae (M. hyopneumoniae) is the hybridization and Polymerase Chain Reaction (PCR). These primary etiological agent of the Swine Enzootic Pneumonia (SEP), techniques are faster and more specific for microorganism that leads to a non-productive cough, mild fever, weight gain detection (6); and since mycoplasmas isolation is impractical in loss, high morbidity, and low mortality (12,17).
    [Show full text]
  • Design & Fabrication of Microfluidic DNA Extraction Device for Water
    DESIGN & FABRICATION OF MICROFLUIDIC DNA EXTRACTION DEVICE FOR WATER QUALITY MONITORING DESIGN & FABRICATION OF MICROFLUIDIC DNA EXTRACTION DEVICE FOR WATER QUALITY MONITORING By Bo Dang, B.ENG. B. Eng. (McMaster University, Ontario, Canada) A Thesis Submitted to the School of Graduate Studies In Partial Fulfillment of the Requirements For the Degree Master of Applied Science McMaster University © Copyright by Bo Dang, September 2012 MASTER OF APPLIED SCIENCE (2012) McMaster University (Mechanical Engineering) Hamilton, Ontario, Canada TITLE DESIGN & FABRICATION OF A MICROFLUIDIC DNA EXTRACTION DEVICE FOR WATER QUALITY MONITORING AUTHOR Bo Dang, B.Eng. SUPERVISOR Professor P. R. Selvaganapathy Department of Mechanical Engineering NUMBER OF PAGES XIX, 119 i ABSTRACT Continuous monitoring of pathogens that may be present in water is one of the key preventive measures that can be used in rural areas of developed countries and developing countries to reduce chances of the water borne diseases outbreak. Off-site testing of microbiological contamination of water is conventionally done for monitoring water quality. However, such a process is time consuming and involves using a variety of hazardous reagents. To address these issues, a portable device for rapid detection of unsafe water is needed. One of the key components in this system is to extract DNA from the pathogens. The primary consideration for DNA extraction is to separate DNA from proteins and other cell debris in the lysate solution. The pure population of DNA molecules are then sent downstream for subsequent processing such as real-time PCR (Polymerase Chain Reaction) and BioFET sensors for further identification and analysis. The focus of the thesis will be on the fabrication of a microfluidic DNA extraction system that can achieve high DNA extraction efficiency and a good repeatability.
    [Show full text]
  • RNA Extraction and Quantification, Reverse Transcription, and Real
    RNA Extraction and Quantification, Reverse Transcription, and Real-time PCR (q-PCR) General Surgery Labs SOP 9-10-2014 Sladjana Stratomirovic RNA Extraction and Quantification, Reverse Transcription, and Real-time PCR (q-PCR) Preparation of Samples Cells: o Remove media and wash cells 2X with cold PBS. (2 ml for 6 well plate or 3 ml for 6cm plate) . Keep on ice at all times! o Add 200-500 ul cold PBS o Scrape cells and collect a 1.5 eppendorf tube o Spin down to collect pellet at 12000 rpm for 10 min (4 degree) o Remove PBS completely . store the pellet at -80 freezer if you are not extracting RNA immediately Snap frozen tissue: o Homogenize tissue by placing it in liquid nitrogen-cooled aluminum foil and crushing it into fine pieces (using a hammer) for use in Western blots, RNA extractions etc. Only a small amount of tissue is needed for RNA extraction (20-30 mg) o The rest of the homogenized tissue can be aliquoted and stored at -80. RNA Extraction RNA extraction is done using different RNA extraction kits specific for certain cells, tissue, blood, etc. You can learn more about different kits for different tissues on the Qiagen website: http://www.qiagen.com. The RNeasy Mini Kit from Qiagen is the kit used most often in our lab. The kit is supplied with a Quick–Start protocol for RNA extraction. You can find more detailed explanation in the Qiagen handbook on their website:www.qiagen.com/handbooks. Notes before start using Qiagen kit: Add 10ul β –mercacptoethanol (β-ME) to 1ml RLT buffer provided in the kit.
    [Show full text]
  • Development of an RNA Extraction Protocol for Norovirus from Raw Oysters and Detection by Qrt-PCR and Droplet-Digital RT-PCR
    foods Article Development of an RNA Extraction Protocol for Norovirus from Raw Oysters and Detection by qRT-PCR and Droplet-Digital RT-PCR Daniel Plante 1 , Julio Alexander Bran Barrera 1, Maude Lord 1, Irène Iugovaz 1 and Neda Nasheri 2,3,* 1 Microbiology Laboratory, Regulatory Operations and Enforcement Branch, Health Canada, 1001 St-Laurent Street West, Longueil, QC J4K 1C7, Canada; [email protected] (D.P.); [email protected] (J.A.B.B.); [email protected] (M.L.); [email protected] (I.I.) 2 National Food Virology Reference Centre, Bureau of Microbial Hazards, Food Directorate, Health Canada, 251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0K9, Canada 3 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada * Correspondence: [email protected] Abstract: Foodborne viruses such as norovirus and hepatitis A virus cause frequent outbreaks associated with the consumption of raw or undercooked oysters. Viral particles are bioaccumulated in the oyster’s digestive glands, making RNA extraction and RT-PCR detection difficult due to the complex nature of the food matrix and the presence of RT-PCR inhibitors. Herein, we have developed a viral RNA extraction protocol from raw oysters using murine norovirus (MNV) as a surrogate for human noroviruses. The method combines lysis in Tri-Reagent reagent, followed by RNA extraction using Direct-Zol purification columns and lithium chloride precipitation. Viral load Citation: Plante, D.; Bran Barrera, J.A.; Lord, M.; Iugovaz, I.; Nasheri, N. quantification was performed by both qRT-PCR and droplet-digital RT-PCR.
    [Show full text]
  • Tularemia – Epidemiology
    This first edition of theWHO guidelines on tularaemia is the WHO GUIDELINES ON TULARAEMIA result of an international collaboration, initiated at a WHO meeting WHO GUIDELINES ON in Bath, UK in 2003. The target audience includes clinicians, laboratory personnel, public health workers, veterinarians, and any other person with an interest in zoonoses. Tularaemia Tularaemia is a bacterial zoonotic disease of the northern hemisphere. The bacterium (Francisella tularensis) is highly virulent for humans and a range of animals such as rodents, hares and rabbits. Humans can infect themselves by direct contact with infected animals, by arthropod bites, by ingestion of contaminated water or food, or by inhalation of infective aerosols. There is no human-to-human transmission. In addition to its natural occurrence, F. tularensis evokes great concern as a potential bioterrorism agent. F. tularensis subspecies tularensis is one of the most infectious pathogens known in human medicine. In order to avoid laboratory-associated infection, safety measures are needed and consequently, clinical laboratories do not generally accept specimens for culture. However, since clinical management of cases depends on early recognition, there is an urgent need for diagnostic services. The book provides background information on the disease, describes the current best practices for its diagnosis and treatment in humans, suggests measures to be taken in case of epidemics and provides guidance on how to handle F. tularensis in the laboratory. ISBN 978 92 4 154737 6 WHO EPIDEMIC AND PANDEMIC ALERT AND RESPONSE WHO Guidelines on Tularaemia EPIDEMIC AND PANDEMIC ALERT AND RESPONSE WHO Library Cataloguing-in-Publication Data WHO Guidelines on Tularaemia.
    [Show full text]
  • Bacterial RNA Extraction and Purification from Whole Human
    Technical Note pubs.acs.org/ac Bacterial RNA Extraction and Purification from Whole Human Blood Using Isotachophoresis Anita Rogacs, Yatian Qu, and Juan G. Santiago* Department of Mechanical Engineering, Stanford University, Stanford, California, 94305 *S Supporting Information ABSTRACT: We demonstrate a novel assay for physico- chemical extraction and isotachophoresis-based purification of 16S rRNA from whole human blood infected with Pseudomonas putida. This on-chip assay is unique in that the extraction can be automated using isotachophoresis in a simple device with no moving parts, it protects RNA from degradation when isolating from ribonuclease-rich matrices (such as blood), and produces a purified total nucleic acid sample that is compatible with enzymatic amplification assays. We show that the purified RNA is compatible with reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and demonstrate a clinically relevant sensitivity of 0.03 bacteria per nanoliter using RT-qPCR. ucleic acid amplification methods, including reverse magnetic beads. These approaches are well-established in N transcription-quantitative polymerase chain reaction traditional settings but require multiple reagent wash steps and (RT-qPCR), targeting the 16S rRNA (16S rRNA) enable fast specialized fabrication or manipulation (e.g., pumping liquids and specific detection of bacteria in complex samples such as for wash steps or moving magnets for beads). Further, SPE whole blood.1,2 16S rRNA is a universal constituent of bacterial binding capacity can be low due to competitive protein ribosomes present at high copy numbers (103−104 per actively absorptions (e.g., to silica) and the presence of PCR inhibiting 3,4 growing cell). Targeting these biomarkers can potentially chemistry such as guanidinium thiocyanate (GuCN), guanidi- increase assay sensitivity compared with the assays targeting the nium chloride (GuHCl), isopropyl alcohol, or ethanol.
    [Show full text]